Predicting Future Human and Environmental Health Challenges: The Health and Environmental Sciences Institute's Scientific Mapping Exercise

REFERENCES

• R. Albertini, M. G. Bird, and et al (2006). The use of biomonitoring data in exposure and human health risk assessment. Environ. Health Perspect 114:1755–1762.
   PubMed Web of Science ®Google Scholar
• D. V. Bates. (1995). The effects of air pollution on children. Environ. Health Perspect 103 (Suppl. B):49–53.
   PubMedGoogle Scholar
• M. N. Blumenthal. (2000). Genetics of asthma and allergy. Allergy Asthma Proc 21 (1):55–59.
   PubMed Web of Science ®Google Scholar
• A. R. Boobis, S. M. Cohen, and et al (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol 36:781–792.
   PubMed Web of Science ®Google Scholar
• J. P. Boyle, A. A. Honeycutt, and et al (2001). Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the U.S. Diabetes Care. 24:1936–1940.
   Google Scholar
• R. L. Brent. (2004). Environmental causes of human congenital malformations: The pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics Supplement 113 (4):957–968.
   PubMed Web of Science ®Google Scholar
• R. L. Brent, and M. Weitzman. (2004). The current state of knowledge about the effects, risks and science of children's environmental exposures: Concluding remarks. Pediatrics Supplement 113 (4):1158–1166.
   PubMed Web of Science ®Google Scholar
• R. L. Brent, S. Tanski, and et al (2004). A pediatric perspective on the unique vulnerability and resilience of the embryo and child to environmental toxicants: The importance of rigorous research concerning age and agent. Pediatrics Supplement 113 (4):935–944.
   PubMed Web of Science ®Google Scholar
• P. O. Brown, and L. Hartwell. (1998). Genomics and human disease—Variations on variation. Nature Genetics 18:91–93.
   PubMed Web of Science ®Google Scholar
• S. W. Burchiel, C. M. Knall, and et al (2001). Analysis of genetic and epigenetic mechanisms of toxicity: potential roles of toxicogenomics and proteomics in toxicology. Toxicol. Sci 59:193–195.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (1997). Update: Blood lead levels—United States, 1991–1994. MMWR Morb. Mortal. Wkly. Rep 46 (7):141–145.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (2003). Public health and aging: trends in aging—United States and worldwide. National Center for Chronic Disease Prevention and Health Promotion. MMWR Morb. Mortal. Wkly. Rep 52 (06):101–106.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention, and (2007a). US obesity trends. Available at http://www.cdc.gov/nccdphp/dnpa/obesity/trend/maps/index.htm (accessed 22 September 2008)..
   Google Scholar
• Centers for Disease Control and Prevention. (2007b). Chronic disease notes and reports: special focus. National Center for Chronic Disease Prevention and Health Promotion. Healthy Aging 18:2.
   Google Scholar
• S. M. Cohen. (2004). Human carcinogenesis risk evaluation: an alternative approach to the two-year rodent bioassay. Toxicol. Sci 8:225–229.
   Google Scholar
• S. M. Cohen, A. R. Boobis, and et al (2006). 4-Aminobiphenyl and DNA reactivity: Case study within the context of the 2006 IPCS human relevance framework for analysis of a cancer mode of action for humans. Crit. Rev. Toxicol 36:803–820.
   PubMed Web of Science ®Google Scholar
• C. R.D. Colson, and M.E. De Broe. (2005). Kidney injury from alternative medicines. Adv. Chronic Kidney Dis 12 (3):261–275.
   PubMed Web of Science ®Google Scholar
• Commission of the European Communities. (2000). Communication from the Commission on the precautionary principle. Available at: http://ec.europa.eu/food/food/foodlaw/precautionary/index_en.htm (accessed 22 September 2008)..
   Google Scholar
• E. Corsini, and I. Kimber. (2007). Factors governing susceptibility to chemical allergy. Toxicol. Lett 168 (3):255–259.
   PubMed Web of Science ®Google Scholar
• J.-P. Cosyns, M. Jadoul, and et al (1999). Urothelial lesions in Chinese-herb nephropathy. Am. J. Kidney Dis 33:1011–1017.
   PubMed Web of Science ®Google Scholar
• C. C. Cowie, K. F. Rust, and et al (2006). Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population—National Health and Nutrition Examination Survey 1999–2002. Diabetes Care 29:1263–1268.
   PubMed Web of Science ®Google Scholar
• E. M. Crimmins, and Y. Saito. (2000). Change in the prevalence of diseases among older Americans: 1984–1994. Demographic Res. 3: Article 9. Available at: http://www.demographic-research.org/Volumes/Vol3/9/3-9.pdf (accessed 22 September 2008).
   Google Scholar
• J. R. David, R. C. Browonson, and et al (1993). Family pesticide use and childhood brain cancer. Arch. Environ. Contam. Toxicol 24:87–92.
   PubMed Web of Science ®Google Scholar
• M. S. Daz-Cruz, M.J. Lopez de Alda, and et al (2003). Environmental behaviour and analysis of veterinary and human drugs in soils, sediments and sludge. TrAC Trends Anal. Chem 22 (6):340–351.
   Web of Science ®Google Scholar
• S. S. Devesa, W. J. Blot, and et al (1995). Recent cancer trends in the United States. J. Natl. Cancer Inst 87:175–182.
   PubMed Web of Science ®Google Scholar
• N. G. Doerrer. (2007). Integration of human biomonitoring exposure data into risk assessment: HESI initiatives and perspectives. Int. J. Hyg. Environ. Health 210:247–251.
   PubMed Web of Science ®Google Scholar
• A. K. Done. (1964). Developmental pharmacology. Clin. Pharmacol. Ther 5 (4):432–479.
   PubMed Web of Science ®Google Scholar
• J. Dorne, L. Skinner, and et al (2007). Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology. Anal. Bioanal. Chem 387 (4):1259–1268.
   PubMed Web of Science ®Google Scholar
• M. L. Dourson, S. P. Felter, and et al (1996). Evolution of science-based uncertainty factors in noncancer risk assessment. Reg. Toxicol. Pharmacol 24:108–120.
   PubMed Web of Science ®Google Scholar
• K. Duleba, M. Wysocki, and et al (2006). Complementary and alternative medicine in children with cancer—facts and myths. Adv. Clin. Exper. Med 15 (4):695–703.
   Google Scholar
• Environment Canada. (1999). Canadian Environmental Protection Act 1999. Available at: http://www.ec.gc.ca/CEPARegistry/the_act/default.cfm (accessed 22 September 2008)..
   Google Scholar
• Environment Canada. (2006). Domestic substances list. Available at: http://www.ec.gc.ca/CEPARegistry/subs_list/Domestic.cfm (accessed 22 September 2008)..
   Google Scholar
• R. Etzel. ed. (1999). Handbook of Pediatric Environmental Health. American Academy of Pediatrics, Elk Grove, IL.
   Google Scholar
• European Commission. (2006). Registration, Evaluation, and Authorisation of Chemicals (REACH). Available at: http://ec.europa.eu/environment/chemicals/reach/reach_intro.htm (accessed 22 September 2008)..
   Google Scholar
• European Medicines Agency. (2005). EMEA Conference on Environmental Risk Assessment for Human and Veterinary Medicinal Products. 27–28 October 2005. Available at: http://www.emea.europa.eu/pdfs/general/direct/pr/35994505.pdf (accessed 22 September 2008)..
   Google Scholar
• Interagency Research Animal Committee. (1985). U.S. government principles for the utilization and care of vertebrate animals used in testing, research, and training. Available at: http://grants.nih.gov/grants/olaw/references/phspol.htm#USGovPrinciples (accessed 22 September 2008)..
   Google Scholar
• K. M. Flegal, M. D. Carroll, and et al (2002). Prevalence and trends in obesity among U.S. adults, 1999–2000. J. Am. Med. Assoc 288 (14):1723–1727.
   PubMed Web of Science ®Google Scholar
• P. B. Fontanarosa, D. Rennie, and et al (2003). The need for regulation of dieting supplements—lessons from ephedra. J. Am. Med. Assoc 289:1568–1570.
   PubMed Web of Science ®Google Scholar
• F. W. Fraunfelder. (2005). Ocular side effects associated with dietary supplements and herbal medicines. Drugs of Today 41 (8):537–545.
   PubMed Web of Science ®Google Scholar
• M. Gallo. (2001). History and scope of toxicology. In: Casarett and Doull's Toxicology: The Basic Science of Poisons, 5th ed,C.D. Klaassen,. ed., pp. 3–10. McGraw–Hill, New York.
   Google Scholar
• G. Ginsberg, D. Hattis, and et al (2004). Pediatric pharmacokinetic data: Implications for environmental risk assessment for children. Pediatrics Supplement 113 (4):973–983.
   PubMed Web of Science ®Google Scholar
• E. L. Gold, J. Gordis, and et al (1979). Risk factors for brain tumors in children. Am. J. Epidemiol 109:309–319.
   PubMed Web of Science ®Google Scholar
• L. R. Goldman, and S. Koduru. (2000). Chemicals in the environment and developmental toxicity to children: A public health and policy perspective. Environ. Health Perspect 108 (Suppl. 3):443–448.
   PubMedGoogle Scholar
• H. Greim, M. Arand, and et al (2006). Toxicological comments to the discussion about REACH. Arch. Toxicol 80:121–124.
   PubMed Web of Science ®Google Scholar
• G. A. Gronert, J. Mott, and et al (1988). Aetiology of malignant hyperthermia. Br. J. Anaesth 60:253–267.
   PubMed Web of Science ®Google Scholar
• D. Gulezian, and D. Jacobson-Kram. (2000). Use of transgenic animals for carcinogenicity testing: Consideration and implications for risk assessment. Toxicol. Pathol. 28 (3):482–499.
   PubMed Web of Science ®Google Scholar
• P. Guzelian, C. Henry, and et al (1992). Similarities and differences between children and adults: Implications for risk assessment. ILSI Press, Washington, DC.
   Google Scholar
• Health and Safety Executive. (2007). The precautionary principle: Policy and application. Available at: http://www.hse.gov.uk/aboutus/meetings/committees/ilgra/pppa.htm (accessed 22 September 2008)..
   Google Scholar
• J. J. Hoet, S. Ozanne, and et al (2000). Influences of pre- and postnatal nutritional exposures on vascular/endocrine systems in animals. Environ. Health Perspect 108 (Suppl. 3):563–568.
   PubMedGoogle Scholar
• S. Holladay, and R. J. Smialowicz. (2000). Development of the murine and human immune system: Differential effects of immunotoxicants depend on time of exposure. Environ. Health Perspect 108 (Suppl. 3):463–473.
   PubMed Web of Science ®Google Scholar
• M. P. Holsapple, W. H. Farland, and et al (2005). Research strategies for safety evaluation of nanomaterials, part II: Toxicological and safety evaluation of nanomaterials, current challenges and data needs. Toxicol. Sci 88 (1):12–17.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine of the National Academies. (2005). Complementary and alternative medicine in the United States. Board on Health Promotion and Disease Prevention. The National Academies Press, Washington, DC.
   Google Scholar
• Interagency Coordinating Committee on the Validation of Alternative Methods. (2007). The NICEATM-ICCVAM Five-Year Plan (2008–2012). Draft: May 4, 2007. Available at: http://iccvam.niehs.nih.gov/docs/about_docs/5YRPlan04May07FD.pdf (accessed 22 September 2008)..
   Google Scholar
• Joint Nature Conservation Committee. (2007). The precautionary principle and approach. Available at: http://www.jncc.gov.uk/default.aspx?page=2519 (accessed 22 September 2008)..
   Google Scholar
• D. Kirkland, M. Aardema, and et al (2005). Evaluation of the ability of a battery of three genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. 1. Sensitivity, specificity and relative predictivity. Mutat. Res 584:1–256.
   PubMed Web of Science ®Google Scholar
• D. J. Kirkland, M. Hayashi, and et al (2007a). The International Workshops on Genotoxicity Testing (IWGT): History and achievements. Mutat. Res 627:1–4.
   PubMed Web of Science ®Google Scholar
• D. J. Kirkland, M. Hayashi, and et al (2007b). Summary of major conclusions from the 4th IWGT, San Francisco, 9–10 September, 2005. Mutat. Res 627:5–9.
   PubMed Web of Science ®Google Scholar
• M. Kollmann, and V. Sourjik. (2007). In silico biology: From simulation to understanding. Curr. Biol 17:R132–R134.
   Web of Science ®Google Scholar
• P. Lichtenstein, N. V. Holm, and et al (2000). Environmental and heritable factors in the causation of cancer. New Engl. J. Med 343:78–85.
   PubMed Web of Science ®Google Scholar
• W. Loging, L. Harland, and et al (2007). High-throughput electronic biology: Mining information for drug discovery. Nat. Rev. Drug Discov 6:220–230.
   PubMed Web of Science ®Google Scholar
• J. MacDonald, J. E. French, and et al (2004). The utility of transgenic assays for risk assessment. Toxicol. Sci 77:188–194.
   PubMedGoogle Scholar
• A. Majeed, and P. Aylin. (2005). The ageing population of the United Kingdom and cardiovascular disease. Brit. Med. J 331:1362.
   PubMedGoogle Scholar
• J. E. Manson, and S. S. Bassuk. (2003). Obesity in the United States. A fresh look at its high toll. J. Am. Med. Assoc 289:229–230.
   PubMed Web of Science ®Google Scholar
• J. T. Mayne, W. W. Ku, and et al (2006). Informed toxicity assessment in drug discovery: Systems-based toxicology. Curr. Opin. Drug Discov. Devel 9:75–83.
   PubMed Web of Science ®Google Scholar
• G. McCarver. (2004). Applicability of the principles of developmental pharmacology to the study of environmental toxicants. Pediatrics Supplement 113 (4):969–972.
   PubMed Web of Science ®Google Scholar
• M. E. Meek, J. R. Bucher, and et al (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol 33:591–596.
   PubMed Web of Science ®Google Scholar
• R. W. Miller. (1995). Special susceptibility of the child to certain radiation-induced cancers. Environ. Health Perspect 103 (Suppl. 6):41–44.
   PubMedGoogle Scholar
• A. H. Mokdad, M. K. Serdula, and et al (1999). The spread of the obesity epidemic in the United States, 1991–1998. J. Am. Med. Assoc 282:1519–1522.
   PubMed Web of Science ®Google Scholar
• A. H. Mokdad, B. A. Bowman, and et al (2001). The continuing epidemics of obesity and diabetes in the United States. J. Am. Med. Assoc 286:1195–1200.
   PubMed Web of Science ®Google Scholar
• A. H. Mokdad, E. S. Ford, and et al (2003). Prevalence of obesity related health risk factors. J. Am. Med. Assoc 289:76–79.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. (1999). Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. NIH Publication Number 99–4649.
   Google Scholar
• National Institute for Clinical Health and Excellence. (2003). Management of obesity and overweight (evidence briefing summary). Available at: http://www.nice.org.uk/page.aspx?o=502625 (accessed 22 September 2008)..
   Google Scholar
• National Research Council. (1993). Pesticides in the diets of infants and children. National Academy Press, Washington, DC.
   Google Scholar
• National Research Council. (1996). Carcinogens and anticarcinogens in the human diet. The National Academies Press, Washington, DC.
   Google Scholar
• National Research Council. (2006). Human biomonitoring for environmental chemicals. The National Academies Press, Washington, DC.
   Google Scholar
• National Research Council. (2007). Toxicity testing in the twenty-first century: A vision and a strategy. National Academies Press, Washington, DC.
   Google Scholar
• H. L. Needleman, A. Schell, and et al (1990). The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N. Engl. J. Med 322:83–88.
   PubMed Web of Science ®Google Scholar
• M. Nieuwenhuijsen, D. Paustenbach, and et al (2006). New developments in exposure assessment: The impact on the practice of health risk assessment and epidemiological studies. Environ. Int 32:996–1009.
   PubMed Web of Science ®Google Scholar
• B. Niggemann, and C. Gruber. (2003). Side-effects of complementary and alternative medicine. Allergy 58 (8):707–716.
   PubMed Web of Science ®Google Scholar
• K. Olden. (2004). Genomics in environmental health research—Opportunities and challenges. Toxicology 198:19–24.
   PubMed Web of Science ®Google Scholar
• A. F. Olshan, N. E. Breslow, and et al (1993). Risk factors for Wilm's Tumor: Report from the National Wilm's Tumor Study. Cancer 72:938–944.
   PubMed Web of Science ®Google Scholar
• S. Patel, D. Parmar, and et al (2005). Contribution of genomics, proteomics and single-nucleotide polymorphism in toxicology research and Indian scenario. Indian J. Hum. Genet 11:61–75.
   Google Scholar
• W. Pennie, S. D. Pettit, and et al (2004). Toxicogenomics in risk assessment: an overview of an ILSI HESI collaborative research program. Environ. Health Perspect. Toxicogenomics 112:417–419.
   PubMed Web of Science ®Google Scholar
• M. P. Pirmohamed, S. James, and et al (2004). Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. Brit. Med. J 329:15–19.
   PubMed Web of Science ®Google Scholar
• C Raffensperger, and J Tickner. (1999). Protecting public health and the environment: Implementing the precautionary principle. Island Press, Washington, DC.
   Google Scholar
• C. K. Redmond. (1981). Sensitive population subsets in relation to effects of low doses. Environ. Health Perspect 42:137–140.
   PubMed Web of Science ®Google Scholar
• L. Ritter, and T. E. Arbuckle. (2007). Can exposure characterization explain concurrence or discordance between toxicology and epidemiology?. Toxicol. Sci 97 (2):241–252.
   PubMed Web of Science ®Google Scholar
• D. Schuster, T. M. Steindl, and et al (2006). Predicting drug metabolism induction in silico. Curr. Top. Med. Chem 6:1627–1640.
   PubMed Web of Science ®Google Scholar
• S. T. Sherry, M.-H. Ward, and et al (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308–311.
   PubMed Web of Science ®Google Scholar
• H. C. Shirkey. (1980). Pediatric therapy. pp. 17–20, CV Mosby, St. Louis.
   Google Scholar
• K. V. Thomas, and P. Sayre. (2005). Research strategies for safety evaluation of nanomaterials, Part 1: Evaluating the human health implications of exposure to nanoscale materials. Toxicol. Sci 87 (2):316–321.
   PubMed Web of Science ®Google Scholar
• V. Thybaud, M. Aardema, and et al (2007). Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiative. Mutat. Res (in press.)
   Web of Science ®Google Scholar
• J. Tickner, C. Raffensperger, and et al (1998). The precautionary principle in action. A handbook. Available at: http://www.biotech-info.net/handbook.pdf (accessed 22 September 2008)..
   Google Scholar
• US Environmental Protection Agency. (2004). The children's environmental health yearbook supplement. Office of Children's Health Protection. EPA-100-R-00-0018, Washington, DC.
   Google Scholar
• US Environmental Protection Agency. (2005). Toxicity and exposure assessment for children's health. (TEACH: A database of toxicity information). Available at: http://www.epa.gov/TEACH/ (accessed October 1, 2008)..
   Google Scholar
• US Environmental Protection Agency. (2006). A framework for assessing health risks of environmental exposures to children. Publication Number EPA/600/R-05/093A..
   Google Scholar
• US Environmental Protection Agency. (2007). Guide to considering children's health when ceveloping EPA actions: Implementing executive order 13045. Washington, DC.
   Google Scholar
• US Food and Drug Administration. (2005). Guidance for industry: Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Available at: http://www.fda.gov/cder/guidance/5541fnl.htm (accessed 22 September 2008)..
   Google Scholar
• W. W. Weber, D. W. Hein, and et al (1983). Relationship of acetylators status to isoniazid toxicity, lupus erythematosus, and bladder cancer. FASEB J. 42:3086–3097.
   Google Scholar
• A. V. Weisbrod, L. P. Burkhard, and et al (2007). Workgroup report: Review of fish bioaccumulation databases used to identify persistent, bioaccumulative, toxic substances. Environ. Health Perspect. 115:255–261.
   PubMed Web of Science ®Google Scholar
• P. Wiffen, M. Gill, and et al (2002). Adverse drug reactions in hospital patients: A systematic review of the prospective and retrospective studies. Bandolier Extra—Evidence-Based Healthcare.
   Google Scholar
• J. Wilmoth, and C. F. Longino. (2006). Demographic trends that will shape U.S. policy in the twenty-first century. Res. Aging 28 (3):269–288.
   Web of Science ®Google Scholar
• K. N. Woodward. (2005). The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Hum. Exper. Toxicol 24 (5):219–233.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (1998). Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO/NUT/NCD/981, WHO, Geneva, Switzerland.
   Google Scholar
• World Health Organization. (2006). Obesity and overweight. Fact sheet number 311. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed 22 September 2008)..
   Google Scholar
• J. Zurlo, D. Rudacille, and et al (1994). Animals and alternatives in testing: History, science, and ethics. Mary Ann Liebert, Inc., New York.
   Google Scholar